The evolution of invasive pulmonary aspergillosis on chest imaging in response to antifungal therapy.
作者信息
Chong Woon H, Ibrahim Ammoura, Saha Biplab Kumar
机构信息
Pulmonary and Critical Care Medicine, Albany Medical Center, Albany, New York, USA.
Department of Pathology, Albany Medical Center, Albany, New York, USA.
出版信息
BMJ Case Rep. 2021 Mar 22;14(3):e242576. doi: 10.1136/bcr-2021-242576.
Abstract
摘要
相似文献
1
The evolution of invasive pulmonary aspergillosis on chest imaging in response to antifungal therapy.侵袭性肺曲霉病在胸部影像学上对抗真菌治疗的反应演变。
BMJ Case Rep. 2021 Mar 22;14(3):e242576. doi: 10.1136/bcr-2021-242576.
2
Radiologically Occult Invasive Pulmonary Aspergillosis in a Patient With Liver Transplant.肝移植患者的放射学隐匿性侵袭性肺曲霉病
Exp Clin Transplant. 2018 Mar;16 Suppl 1(Suppl 1):176-178. doi: 10.6002/ect.TOND-TDTD2017.P55.
3
Combination antifungal therapy for invasive pulmonary aspergillosis in a heart transplant recipient.心脏移植受者侵袭性肺曲霉病的联合抗真菌治疗
Exp Clin Transplant. 2011 Aug;9(4):279-83.
4
Rare form of semi-invasive aspergillosis in immunocompetent patient: case report.
Pneumologia. 2011 Oct-Dec;60(4):222-4.
5
Clinical manifestations and outcome analysis of invasive pulmonary aspergillosis infection: a retrospective study in 43 nonneutropenic patients.侵袭性肺曲霉病感染的临床表现及结局分析：43例非中性粒细胞减少患者的回顾性研究
J Int Med Res. 2019 Nov;47(11):5680-5688. doi: 10.1177/0300060519874901. Epub 2019 Sep 30.
6
Invasive pulmonary aspergillosis after living donor liver transplantation should be eradicated or not? A case report.活体肝移植术后侵袭性肺曲霉病是否应予以根除？一例病例报告。
Transplant Proc. 2011 Jul-Aug;43(6):2428-30. doi: 10.1016/j.transproceed.2011.05.034.
7
A Multimodal Imaging Approach Enables Assessment of Antifungal Treatment in a Mouse Model of Invasive Pulmonary Aspergillosis.多模态影像学方法可用于评估侵袭性肺曲霉病小鼠模型中的抗真菌治疗效果。
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00240-18. Print 2018 Jul.
8
Invasive pulmonary aspergillosis after near-drowning.近乎溺水后发生的侵袭性肺曲霉病
Lancet Infect Dis. 2016 Dec;16(12):1430. doi: 10.1016/S1473-3099(16)30202-X. Epub 2016 Nov 15.
9
Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes.实体瘤患者侵袭性肺曲霉病：危险因素和临床结局的预测因素。
Ann Med. 2018 Dec;50(8):713-720. doi: 10.1080/07853890.2018.1518581. Epub 2018 Sep 29.
10
Timing of broncho-alveolar lavage for galactomannan testing in hematological oncology patients.血液肿瘤患者中用于半乳甘露聚糖检测的支气管肺泡灌洗时机
Clin Respir J. 2017 Jul;11(4):534-536. doi: 10.1111/crj.12380. Epub 2015 Oct 2.
引用本文的文献
1
Angioinvasive aspergillosis in a patient with acute myeloid leukemia and influenza B virus infection.一名急性髓系白血病合并乙型流感病毒感染患者的血管侵袭性曲霉病
J Bras Pneumol. 2024 Jan 15;49(6):e20230228. doi: 10.36416/1806-3756/e20230228.
2
Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis.比较 COVID-19 相关肺曲霉病（CAPA）的临床特征和结局：系统评价和荟萃分析。
Infection. 2022 Feb;50(1):43-56. doi: 10.1007/s15010-021-01701-x. Epub 2021 Sep 27.
本文引用的文献
1
Pulmonary Aspergillosis: What the Generalist Needs to Know.肺曲霉病：全科医生应知应会
Am J Med. 2020 Jun;133(6):668-674. doi: 10.1016/j.amjmed.2020.02.025. Epub 2020 Mar 30.
2
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.伊曲康唑与伏立康唑治疗曲霉菌和其他丝状真菌所致侵袭性霉菌病的初步治疗（SECURE）：一项 3 期随机对照非劣效性试验。
Lancet. 2016 Feb 20;387(10020):760-9. doi: 10.1016/S0140-6736(15)01159-9. Epub 2015 Dec 10.
3
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.侵袭性真菌病临床试验中治疗反应和研究结果的定义：真菌病研究组和欧洲癌症研究与治疗组织共识标准
Clin Infect Dis. 2008 Sep 1;47(5):674-83. doi: 10.1086/590566.
4
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.对侵袭性真菌病患者进行伏立康唑治疗药物监测可改善疗效和安全性结果。
Clin Infect Dis. 2008 Jan 15;46(2):201-11. doi: 10.1086/524669.
5
Invasive aspergillosis in the intensive care unit.重症监护病房中的侵袭性曲霉病
Clin Infect Dis. 2007 Jul 15;45(2):205-16. doi: 10.1086/518852. Epub 2007 Jun 13.
6
Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign.急性侵袭性肺曲霉病的影像学表现：晕征的临床意义。
Clin Infect Dis. 2007 Feb 1;44(3):373-9. doi: 10.1086/509917. Epub 2006 Dec 29.
7
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.伏立康唑与两性霉素B用于侵袭性曲霉病的初始治疗比较
N Engl J Med. 2002 Aug 8;347(6):408-15. doi: 10.1056/NEJMoa020191.
8
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.伏立康唑与两性霉素B脂质体用于中性粒细胞减少症伴持续发热患者的经验性抗真菌治疗比较。
N Engl J Med. 2002 Jan 24;346(4):225-34. doi: 10.1056/NEJM200201243460403.
9
The air crescent sign.空气半月征
Radiology. 2001 Jan;218(1):230-2. doi: 10.1148/radiology.218.1.r01ja19230.
10
Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia.中性粒细胞减少症患者连续胸部计算机断层扫描中侵袭性肺曲霉病的体积增加及特征变化
J Clin Oncol. 2001 Jan 1;19(1):253-9. doi: 10.1200/JCO.2001.19.1.253.
Zotero 插件